• Explore /
  • Poster
  • / A multicenter phase II trial to assess the efficacy and safety of bevacizumab plus mFOLFOX6 as induction chemotherapy toward R0 surgical resection in advanced colorectal liver metastases with mutant-type KRAS: NEXTO-mt trial.

A multicenter phase II trial to assess the efficacy and safety of bevacizumab plus mFOLFOX6 as induction chemotherapy toward R0 surgical resection in advanced colorectal liver metastases with mutant-type KRAS: NEXTO-mt trial.

Abstract Video & Slides Poster

Authors

null

Genki Watanabe

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

Genki Watanabe , Yoshihiro Mise , Masaru Oba , Akio Saiura , Yosuke Inoue , Yu Takahashi , Yoji Kishi , Koichi Suyama , Tadatoshi Takayama , Tamaki Noie , Yujiro Nishioka , Nobuhisa Akamatsu , Junichi Arita , Norihiro Kokudo , Kiyoshi Hasegawa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

000009530

DOI

10.1200/JCO.2022.40.4_suppl.450

Abstract #

450

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Thomas Gruenberger

First Author: Valerie Boige

First Author: Hiroyuki Uetake

First Author: Marta Caporale